Bioter SA Valuation
BIOT Stock | EUR 0.25 0.00 0.00% |
Bioter SA seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Bioter SA from analyzing the firm fundamentals such as Current Valuation of 166.03 M, shares owned by insiders of 41.74 %, and Return On Asset of -0.0136 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Bioter SA's price fluctuation is out of control at this time. Calculation of the real value of Bioter SA is based on 3 months time horizon. Increasing Bioter SA's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Bioter SA's intrinsic value may or may not be the same as its current market price of 0.25, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 0.25 | Real 0.23 | Hype 0.25 |
The intrinsic value of Bioter SA's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Bioter SA's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Bioter SA helps investors to forecast how Bioter stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bioter SA more accurately as focusing exclusively on Bioter SA's fundamentals will not take into account other important factors: Bioter SA Total Value Analysis
Bioter SA is currently anticipated to have takeover price of 166.03 M with market capitalization of 5.82 M, debt of 143.2 M, and cash on hands of 255 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Bioter SA fundamentals before making investing decisions based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
166.03 M | 5.82 M | 143.2 M | 255 K |
Bioter SA Investor Information
About 42.0% of the company shares are held by company insiders. The company last dividend was issued on the 18th of August 2006. Bioter SA had 0:1 split on the 9th of August 2010. Based on the key measurements obtained from Bioter SA's financial statements, Bioter SA is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.Bioter SA Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Bioter SA has an asset utilization ratio of 0.24 percent. This implies that the Company is making 0.00241 for each dollar of assets. An increasing asset utilization means that Bioter SA is more efficient with each dollar of assets it utilizes for everyday operations.Bioter SA Ownership Allocation
Bioter SA holds a total of 16.73 Million outstanding shares. Bioter SA retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Bioter SA Profitability Analysis
The company reported the revenue of 241 K. Net Loss for the year was (8.81 M) with loss before overhead, payroll, taxes, and interest of (935 K).About Bioter SA Valuation
The stock valuation mechanism determines Bioter SA's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Bioter SA based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bioter SA. We calculate exposure to Bioter SA's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bioter SA's related companies.8 Steps to conduct Bioter SA's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Bioter SA's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Bioter SA's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Bioter SA's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Bioter SA's revenue streams: Identify Bioter SA's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Bioter SA's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Bioter SA's growth potential: Evaluate Bioter SA's management, business model, and growth potential.
- Determine Bioter SA's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Bioter SA's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Bioter Stock Analysis
When running Bioter SA's price analysis, check to measure Bioter SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioter SA is operating at the current time. Most of Bioter SA's value examination focuses on studying past and present price action to predict the probability of Bioter SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioter SA's price. Additionally, you may evaluate how the addition of Bioter SA to your portfolios can decrease your overall portfolio volatility.